Innovative venture capital firm will leverage SS&C's fund administration services and Intralinks' InvestorVision for fund
MiRus Receives FDA 510(K) Clearance For The Lowest Profile and Best-in-class Expandable Lumbar Interbody
MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody.
High-net-worth clients are interested in private investments, and Mammoth Scientific, which just rolled out a venture capital fund, aims to provide such products to the RIA channel, say two of its founders, Jud Mackrill and Tommy Martin.
MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®). The round was led by Mammoth Scientific and multi-generational family offices who have supported MiRus from its inception.